LHHealthcarelabcorp.com
| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $3.33B | $3.35B | $3.53B | $3.56B | $3.52B | $3.54B | $3.73B | $3.81B | ▲ +6.9% |
| Gross profit | $896.30M | $948.00M | $1.05B | $1.03B | $993.20M | $1.01B | $1.11B | $1.11B | ▲ +8.1% |
| Operating income | $216.50M | $326.00M | $394.50M | $396.60M | $267.60M | $380.80M | $451.60M | $402.10M | ▲ +1.4% |
| Net income | $143.40M | $212.80M | $237.90M | $261.10M | $164.70M | $277.80M | $298.70M | $262.80M | ▲ +0.7% |
| R&D | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 2.52 $ | 2.84 $ | 3.12 $ | — | 3.35 $ | 3.64 $ | 3.22 $ | ▲ +3.2% |
| Margins (% of revenue) | |||||||||
| Gross | 26.9 % | 28.3 % | 29.7 % | 28.8 % | 28.2 % | 28.7 % | 29.8 % | 29.1 % | ▲ +0.3 pt |
| Operating | 6.5 % | 9.7 % | 11.2 % | 11.1 % | 7.6 % | 10.8 % | 12.1 % | 10.6 % | ▼ -0.6 pt |
| Net | 4.3 % | 6.4 % | 6.7 % | 7.3 % | 4.7 % | 7.9 % | 8.0 % | 6.9 % | ▼ -0.4 pt |
| Balance sheet | |||||||||
| Assets | $18.38B | $17.60B | $18.06B | $18.26B | $18.39B | $19.09B | $18.53B | $18.92B | ▲ +3.6% |
| Liabilities | $10.31B | $9.28B | $9.57B | $9.55B | $9.76B | $10.34B | $9.91B | $10.06B | ▲ +5.4% |
| Equity | $8.05B | $8.31B | $8.47B | $8.70B | $8.62B | $8.73B | $8.61B | $8.85B | ▲ +1.7% |
| Cash | $1.52B | $369.40M | $647.30M | $598.10M | $532.30M | $981.10M | $141.80M | $261.80M | ▼ -56.2% |
| Capital | |||||||||
| Shares outstanding | 83.70M | 83.70M | 83.10M | 82.90M | 82.40M | 82.00M | 81.10M | 81.20M | ▼ -2.1% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.